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Abstract. Muscle development involves a series of 
complex cell-cell interactions that are mediated, at 
least in part, by several different cell adhesion mole- 
cules. Previous work from this lab showed that the dif- 
ferent isoforms of NCAM and its level of polysialyla- 
tion are developmentally regulated during chick 
myogenesis in vivo and that this regulation is important 
for normal muscle development. Using developing 
chick secondary myotubes grown in culture, we show 
here that both the polysialylation of NCAM and the de- 
velopmental switch in isoform expression are regulated 
by activity and that Ca  2÷ entry through voltage-gated 
channels and the subsequent activation of protein ki- 
nase C are required for the developmental changes in 
NCAM isoform synthesis. Specifically, PSA expression 
was shown to be developmentally regulated with high 
expression being temporally correlated with the onset 
of spontaneous contractile activity. Furthermore, 
blocking contractile activity caused a decrease in PSA 
expression, while increasing activity with electrical 
stimulation resulted in its up-regulation. Immunoblot 
and metabolic labeling studies indicated that dividing 
myoblasts synthesize primarily 145-kD NCAM, newly 
formed, spontaneously contracting myotubes synthe- 
size 130-, 145-, and 155-kD NCAM isoforms, while 
older, more mature myotubes primarily synthesize the 
glycosylphosphatidylinositol-anchored 130-kD isoform. 
In addition, mature myotubes synthesized a 180-kD iso- 
form which, in contrast to the other three isoforms, had 
a high rate of turnover. This developmental switch in 
NCAM isoform expression could be inhibited with 
Ca  2÷ channel blockers and inhibitors of protein kinase 
C. Taken together, these results suggest that Ca  2+ ions 
and protein kinase C are involved in a second messen- 
ger cascade coupling membrane depolarization with 
transcriptional factors that regulate NCAM isoform 
synthesis and polysialylation. 
T 
HE neural cell adhesion molecule (NCAM)  1 is de- 
velopmentally expressed on a  wide variety of cell 
types and mediates many cell--cell interactions  in- 
cluding axonal growth (Doherty and Walsh, 1992), fascicu- 
lation (Landmesser et al., 1988), cell migration (Ono et al., 
1994),  and  myogenesis  (reviewed  by McDonald  et  al., 
1995). During skeletal muscle development, NCAM is ex- 
pressed  at  the  onset  of primary  myogenesis,  increases 
throughout secondary myogenesis and eventually declines 
around  the time  of birth  (Covault  and  Sanes,  1986)  or 
hatching (Fredette et al., 1993; Tosney et al., 1986). Skele- 
tal muscle NCAM has at least three major isoforms that 
are generated by alternative splicing of a pre-mRNA that 
Address correspondence to  Dr.  Lynn  Landmesser, Dept.  of Neuro- 
sciences, Case Western Reserve University,  Cleveland,  OH 44106-4975. 
Tel.: (216) 368-8448. Fax: (216) 368-4650. 
1. Abbreviations used in this paper. AChR, acetylcholine receptors; dTC, 
d-tubocurarine;  MSD, muscle-specific domain; NCAM, neural cell adhe- 
sion molecule; PKC, protein kinase C; PNA, peanut agglutinin; PSA, poly- 
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is transcribed from a single gene (Cunningham et al., 1987; 
Owens et al., 1987). Proliferating myoblasts in vitro (Co- 
vault et al., 1986; Moore et al., 1987; Knudsen et al., 1989) 
and primary myotubes in vivo (Fredette et al., 1993) pre- 
dominantly express the 145-kD transmembrane isoform of 
NCAM. However, as development proceeds, both in vivo 
and in culture, the 145-kD isoform is down-regulated and 
the GPI-linked 130-kD isoform of NCAM is up-regulated 
to become the predominant isoform (Covault et al., 1986; 
Fredette et al.,  1993; Yoshimi et al.,  1993). In vivo, this 
large upregulation of the GPI-linked isoform is associated 
with secondary myogenesis (Fredette et al., 1993). 
The factors that regulate the expression of NCAM, and 
in  particular  its  different  isoforms,  are  not well under- 
stood.  NCAM  on  mammalian  skeletal  muscle  fibers  is 
down-regulated postnatally but is rapidly re-expressed fol- 
lowing denervation (Covault and Sanes, 1985, 1986). These 
results indicate that  the overall expression of NCAM in 
neonatal and adult muscle fibers is regulated by muscle ac- 
tivity. However, the role of neuromuscular activity in reg- 
ulating the expression of individual isoforms during em- 
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activity during primary and secondary myogenesis in vivo 
prevents the normal switch from the 145- to the 130-kD 
isoform of NCAM (Fredette et al., 1993), suggesting that 
activity plays a role in regulating this isoform switch. How- 
ever, since activity blockade also results in a dramatic re- 
duction in the total number of secondary myotubes that 
are formed (Fredette and Landmesser, 1991; Harris, 1981; 
Ross  et  al.,  1987),  the  observed  absence  of an  isoform 
switch in activity blocked muscles may simply result be- 
cause  secondary myogenesis is  inhibited. Thus it  is  not 
possible to conclude from these observations that activity 
directly affects NCAM isoform expression. 
Electrical activation of myotubes has also been shown to 
regulate the polysialylation of NCAM. During early stages 
of in vivo myogenesis polysialic acid (PSA) on NCAM is 
low, but as myogenesis proceeds and neuromuscular activ- 
ity increases, PSA is  dramatically up-regulated on myo- 
tubes and then declines (Fredette et al., 1993). Blockade of 
spontaneous neuromuscular activity by chronic treatment 
with d-tubocurarine (dTC) prevented both the expression 
of PSA on myogenic cells and the separation of myotubes 
from clusters (Fredette et al., 1993). 
How might electrical activity regulate NCAM isoform 
expression and PSA? Neuromuscular activity is known to 
be an important factor regulating the expression of acetyl- 
choline  receptors  (AChRs)  both  in  vivo  (reviewed  by 
Changeux et al., 1990)  and in vitro (Betz and Changeux, 
1979;  Changeux et  al.,  1990).  More recent  studies have 
shown  that  the  activity dependent  down  regulation  of 
AChRs is blocked by both voltage-dependent Ca  2÷ chan- 
nel blockers (Fontaine et al., 1987; Klarsfeld et al.,  1989; 
Huang, et al., 1994) and by inhibitors of protein kinase C 
(PKC) (Klarsfeld et al., 1989; Huang et al.,  1992).  Since 
the expression of both AChRs and total NCAM is down- 
regulated by neuromuscular activity, and up-regulated in 
the  absence  of activity, it is  possible that both proteins 
share a common regulatory pathway. 
To examine more closely the role of neuromuscular ac- 
tivity and  potential  downstream  molecular  mechanisms 
regulating the expression of both NCAM isoforms and of 
PSA,  chick secondary myotubes grown in culture  were 
subjected to a  number of controlled experimental para- 
digms designed to alter activity and/or downstream second 
messengers.  We find that the polysialylation of NCAM 
and the developmental switch in isoform expression is reg- 
ulated by activity. Furthermore, Ca  2+ entry through volt- 
aged gated channels and the activation of PKC is required 
for the developmental changes in NCAM isoform synthesis. 
Preliminary results have previously been published in 
abstract form (Rafuse, V., and L. Landmesser. 1994. Soc. 
Neurosci. Abstr. 20:1318). 
Materials and Methods 
Cell Culture 
Myotube cultures were isolated from white leg horn chick pectoral mus- 
cles from stage 38 (Hamburger and Hamilton, 1951)  embryos. Cultures 
prepared for immunofluorescence and metabolic labeling were prepared 
with the following procedure.  Myoblasts were mechanically dissociated 
from myotubes by gently triturating the dissected muscles through two 
fire-polished Pasteur pipettes with openings of 0.75 and 0.5 ram. The cell 
suspension was centrifuged at 1,000 g for 15 s to separate the myoblasts 
from cell debris. The supernatant containing the myoblasts was diluted 
with culture medium to a final concentration of 106 myoblasts/ml. Myo- 
blasts were plated on rat tail collagen (type I; Collaborative Biomedical 
Products, Bedford, MA)-coated glass cover slips (12 mm; Carolina Biolog- 
ical Supply Company) at 50,000 cells/cover slip in 0.5 ml of Ham's F-10 
(supplemented  with  1.26  mM  CaCI2)  containing  10%  horse  serum 
(GIBCO BRL, Gaithersburg, MD), 5% chicken embryo extract, 100 U/ml 
penicillin, and 100 Ixg/ml streptomycin (culture medium) and cultured in 
24-well plastic tissue culture plates. 50% of the culture medium was re- 
placed with fresh medium on day 3 and thereafter every 2 d. Under these 
conditions myotubes routinely began spontaneously contracting on day 3. 
Cultures used for SDS-PAGE immunoblot analysis were prepared as 
above except that myoblasts were plated in collagen-coated 60 mm plastic 
culture dishes at 106 cells/dish in 5 ml medium. No differences were ob- 
served in either the morphology or rate of myogenesis between the two 
culture conditions. As observed with the cultures plated on glass cover- 
slips, myotubes began spontaneously contracting on day 3. 
To examine the effects of electrical activity on NCAM and PSA expres- 
sion, cultured myotubes were either treated with tetrodotoxin (TTX) or 
electrically stimulated. Spontaneous contractile activity was blocked by 
treatment with 5 p.M TI'X (added on day 2) or was increased by electri- 
cally stimulating 7 d  cultured myotubes. As described above, myotubes 
were cultured in 24-well tissue culture plates on collagen-coated glass cov- 
erslips. Stimulating silver electrodes were immersed in the culture me- 
dium and placed on opposites sides of a single well containing spontane- 
ously contracting myotubes. Myotubes were stimulated using a stimulator 
(model $88; Grass Instruments Co., Quincy, MA) that was coupled to an 
integrated circuit (IC) output device that converted monopolar pulses to 
balanced bipolar pulses. The output from the IC device was connected to 
the silver stimulating electrodes with flexible copper wires. The myotubes 
were stimulated with a single pulse (1-ms pulse width at 60 V) every 10 s 
for 3 d. This procedure effectively stimulated N60% of the cultured myo- 
tubes. Myotubes that did not contract when electrically stimulated were 
also never seen to contract spontaneously. The electrical stimulation pa- 
rameters used did not have any detrimental effects on the health of the 
myotubes based on both their morphology and frequency of spontaneous 
contractions. 
Immunofluorescence 
Three antibodies to NCAM were used: 5E, a  monoclonal IgG antibody 
that recognizes all isoforms of NCAM (Frelinger and Rutishauser, 1986), 
4D, a monoclonal IgG antibody that only recognizes the 180-kD NCAM 
isoform (Watanabe et al., 1986),  and 5A5, a monoclonal IgM that recog- 
nizes only the polysialated form of NCAM (Dodd et al., 1988; Acheson et 
al., 1991). For double labeling of both total and PSA forms of NCAM, 5E 
and 5A5 were diluted together in PBS (pH 8.0) and BSA to a final con- 
centration of 1:100 each. 
Cultured cells were washed with PBS and then fixed with cold 3.7% 
formaldehyde for 15 min at room temperature. Fixed cells were washed 
six times (5 min/wash) with PBS and then blocked with 2% BSA/PBS for 
1 h at room temperature. All cells were processed for immunohistochem- 
istry by first incubating them overnight at 4°C in primary antibodies di- 
luted in 2% BSA/PBS. After rinsing with PBS the cells were incubated for 
1.5 h in a mixture of secondary antibodies (Sigma Immunochemicals, St. 
Louis, MO) consisting of fluorescence-conjugated anti-mouse IgG (1:100) 
and rhodamine-conjugated anti-mouse IgM (1:100). After rinsing several 
times in PBS the coverslips were mounted on a  slide and coverslipped 
with a  glycerol and PBS mixture (50:50) containing p-phenylenediamine 
(0.3 mg/ml) to prevent fading. All comparisons for staining intensity were 
performed using the same dilution of antibodies and photographed with 
Kodak  Tri-X  Pan  film using the same exposure settings. Photographs 
were taken with a Nikon Microphot microscope equipped with epifluores- 
cence. 
SDS-PAGE Immunoblotting 
Cultured cells were washed with PBS, harvested in 4 ml of PBS and centri- 
fuged at 5,000 g for 10 min at 4°C. The pellet was re-suspended in extrac- 
tion buffer (50 mM Hepes, 150 mM NaCI, lmM EDTA, 2 mM PMSF, 100 
p~g/ml leupeptin, 0.2 TIU/ml aprotinin,  1%  NP-40)  sonicated for  10 s, 
placed on ice for 1 h and centrifuged for 1 h at 100,000 g (4°C). The con- 
centration  of the  solubilized  proteins  was  determined  (BCA  method; 
Pierce Chemical Co., Rockford, IL) and adjusted to 1 mg/ml. Some ali- 
quots of the extract (25 t-d) were treated with neuraminidase (0.2 U/ml of 
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37°C to remove sialic acid while others from the same sample were treated 
with buffer alone. SDS sample buffer containing dithiothreitol was added 
to each sample, heated for 20 min at 65°C, and then the proteins were sep- 
arated by SDS-PAGE according to the Laemmli method (Laemmli, 1970) 
on a 6% gel. 20 Ixg of total protein was loaded in each lane. Proteins were 
transferred onto Immobilon-P membranes, incubated for I  h with block- 
ing solution (4% milk in TBS), followed by overnight incubation at 4°C 
with 5E diluted in TBS and 1% milk (1:500).  Membranes were washed 
several times with TBS and then they were incubated for 1.5 h with alka- 
line  phosphatase-conjugated  mouse  IgG  secondary  antibody  (1:500; 
Sigma Immunochemicals). Bands were  visualized with  the  BCIP/NBT 
method. 
Peanut Lectin Immunoblots 
5-d-old myotube cultures were washed with PBS, harvested and homoge- 
nized in 200 Ixl of extraction buffer as described above. The extracted pro- 
teins were rotated overnight at 4°C in the presence of 30 Ixl of 5E-conju- 
gated Sepharose beads to immunoprecipitate NCAM. Beads were washed 
four times (1 ml each) with buffer A  (50 mM Tris-HCl, 0.5 M  NaC1,  1% 
NP-40, pH 8), four times with buffer B (50 mM Tris-HCl, 150 mM NaCI, 
0.5% NP-40, 0.1% SDS, pH 8) and one time with extraction buffer (see 
above). Beads were diluted with 30 I~1 of extraction buffer and half the 
sample was incubated with neuraminidase (see above) for 1-2 h at 37~C to 
remove the sialic acid. SDS sample buffer containing dithiothreitol was 
added to each sample, heated for 20 min at 65°C, and then the proteins 
were separated by SDS-PAGE on a  6%  gel. Proteins were transferred 
onto Immobilon-P membranes and were incubated for 1 h with blocking 
solution (4%  milk in TBS). The membranes were then incubated over- 
night at  room  temperature  with  peanut  agglutinin  (PNA)  (10  Ixg/ml; 
Sigma Immunochemicals). PNA was diluted in Hepes-buffered saline (10 
mM Hepes, 0.15 M  NaC1,  0.1  mM CaC12) containing 1% BSA. Treated 
membranes were then washed several times with TBS, incubated for 1 h 
with anti-PNA (anti-arachis hypogaea lectin) (1:10; Sigma Immunochemi- 
cals), washed, and finally incubated for 1.5 h with alkaline phosphatase- 
conjugated rabbit IgG secondary antibody (1:500;  Sigma Immunochemi- 
cals). Bands were visualized with the BCIP/NBT method. Each lane on 
the immunoblot represents half of the total NCAM immunoprecipitated 
from myotubes cultured in a single 60 mm tissue culture dish. 
Metabolic Labeling 
Glass coverslips, containing myotube cultures, were placed in 24-well tis- 
sue culture plates containing 250 Ixl of methionine-free MEM (Sigma Im- 
munochemicals) for 1 h  at 37°C prior to addition of 30 IxCi of [35S]me- 
thionine. Cultures were pulsed for 8 h  at 37°C after which the cells were 
washed at least 15 times (2 ml each) with cold MEM. Washed cells were 
either homogenized immediately or were placed in fresh culture medium 
(see above) and then incubated (chased) for 1 or 2 d. Cells to be homoge- 
nized were scraped from the coverslip, added to 200 p.l extraction buffer 
(see above), sonicated for 10 s, placed on ice for 1 h, and finally centri- 
fuged at 100,000 g for 1 h at 4°C. Vials containing extracted proteins and 
30 ixl of 5E-conjugated Sepharose beads were rotated overnight at 4°C to 
immunoprecipitate NCAM. Beads were washed four times (1  ml each) 
with buffer A, four times with buffer B, and once with extraction buffer 
(see above). Beads were diluted with 30 p,1 of extraction buffer and incu- 
bated with neuraminidase (see  above)  for  1-2 h  at 37°C.  SDS sample 
buffer was added to each sample, heated for 20 rain at 65°C, and then the 
proteins were separated by SDS-PAGE on a 6% gel. Equivalent amounts 
of protein were added to each lane, which represents half of the total 
NCAM immunoprecipitated from myotubes cultured on a single 12 mm 
glass cover slip. Gels were fixed (10% acetic acid, 25% isopropanol, 65% 
water)  for  30  min,  soaked  in  Amplify  (Amersham Corp.,  Arlington 
Heights, IL) for 30 min, and dried on blotting paper using a Bio-Rad drier 
(gel drier model 583; Bio-Rad Laboratories). Dried gels were placed onto 
pre-flashed Hyperfilm-MP (Amersham Corp.)  in an X-ray cassette for 
1 wk at -70°C after which the films were developed using a medical film 
processor (model QX-70; Konica). 
Drug Treatments 
Several pharmaceutical agents were used throughout this study to alter 
normal cellular function. Voltage-sensitive calcium channels were blocked 
with 10 p~M verapamil (Calbiochem-Behring Corp.) (Walsh et al., 1986). 
To increase intracellnlar Ca  2÷ levels myotubes were treated with either 10 
mM thapsigargin (Calbiochem-Behring Corp.) an inhibitor of Ca2+-ATP  - 
ase activity (Thastrup et al., 1990) or with veratradine, a Na channel acti- 
vator (Stallcup, 1977). PKC was inhibited with either 10  -6 M  phorbol 12 
myristate-13-acetate (TPA;  Sigma Immunochemicals) (Tamaoki  et  al., 
1986) or 10  -7 M staurosporine. Finally, phosphatidycholine-specific phos- 
pholipase  C  was selectively inhibited with 30 mM D609  (Calbiochem- 
Behring Corp.)  (Muller-Decker, 1989). Individual drugs were added to 
the myotube cultures on day 4 and remained in the medium for the de- 
scribed times. 
Results 
Immunocytochemical Comparison of 
Total NCAM and Polysialic  Acid Expression 
during Secondary Myogenesis 
Previous work in this laboratory  (Fredette et al.,  1993) 
showed that, while total NCAM is relatively uniformly ex- 
pressed  on  developing  chick  myoblasts  and  myotubes 
throughout primary and  early secondary myogenesis in 
vivo  (St  28-40),  the  amount  of  PSA  associated  with 
NCAM was temporally regulated. Specifically, the inten- 
sity  of  PSA  immunofluorescence was  very  low  during 
early primary myogenesis (St 28), increased slowly during 
late primary and early secondary myogenesis, until the be- 
ginning  of  St  37, at  which  time  PSA  immunostaining 
sharply peaked  (St 38)  correlating with the break up of 
myotube clusters. To better clarify the mechanisms regu- 
lating the temporal pattern of NCAM and PSA expression 
on developing chick muscle in vivo, we used an in vitro 
model of secondary myogenesis where putative regulatory 
factors could be more easily controlled. 
The formation of myotubes in vitro occurs in a series of 
well-timed events. During the first 24 h of myogenesis, myo- 
blasts divided and many began to align into small clusters 
of cells. One day after plating immunofluorescence for to- 
tal NCAM was uniformily distributed along the surfaces of 
all myoblasts (Fig. 1 A). During the next 24 h of myogene- 
sis myoblasts continued to divide and tightly align as long 
strings of cells that began to take the shape of the future 
myotubes. The expression of total NCAM remained high 
during this time period with slightly higher immunostain- 
ing observed between apposed cells (Fig. 1 C). Over the 
next 24 h  virtually all myoblasts fused together to form 
large multinucleated myotubes. When myoblasts were cul- 
tured in Ca  2÷ supplemented F-10 medium, as was done in 
this study, many newly formed myotubes began to exhibit 
frequent spontaneous contractions by the third day of cul- 
ture and many, but not all, remained spontaneously active 
for as long as the myotubes remained in culture. During 
this entire period, overall NCAM staining remained high 
on both newly formed, as well as on older, more mature 
myotubes (Fig. 1, E and G). Thus, in vitro, overall NCAM 
immunostaining did  not  appear  to  be  developmentally 
regulated or to be affected by the onset of spontaneous 
contractility in myotubes. 
In contrast, PSA expression was strongly correlated with 
the onset on electrical activity. Thus, PSA was absent from 
myoblasts at  1 d  after plating  (Fig.  1 B)  and was  only 
weakly expressed on a few myoblasts at 2 d (Fig. 1 D). At 
3-4 d, when myotubes became spontaneously active, PSA 
was expressed at moderate levels by many, but not all (Fig. 
1 F) myotubes. During the next few days PSA levels in- 
creased with some myotubes exhibiting intense staining 
Rafuse and Landmesser Regulation ofNCAM Isoforms  971 Figure 1.  NCAM and PSA ex- 
pression  during  different 
stages  of in vitro myogenesis. 
Cultures  were immunostained 
for NCAM (A, C, E, and G) or 
PSA (B, D, F, and H). At 1 d 
after plating myoblasts express 
NCAM  strongly  (A,  arrow), 
but PSA is weak to absent (B, 
arrow).  At  2  d  NCAM  is 
strongly expressed on all myo- 
blasts  (C, arrow) and PSA be- 
gins to be weakly expressed on 
a few fusing myoblasts (D, ar- 
row). By 3-4 d NCAM staining 
is intense on the newly formed 
myotubes (E, arrow).  PSA ex- 
pression increases on most my- 
otubes (F, arrow), but is weak 
to absent on others (F, arrow- 
head) which are NCAM posi- 
tive  (E,  arrowhead).  By  8  d 
PSA expression has increased 
markedly  on  many  myotubes 
(1t, arrow), but  is still  low to 
absent  on  others  (H,  arrow- 
head).  In  contrast,  NCAM 
staining  is  uniformly high  on 
all myotubes ( G, arrow and ar- 
rowhead). Bar, 75 ixm. 
(Fig.  1 H, arrow).  However, PSA staining remained  het- 
erogeneous and even by day 8  some myotubes which ex- 
pressed NCAM still exhibited weak to absent staining for 
PSA (Fig. 1 H, arrowhead). 
Fredette  et  al.  (1993)  previously showed that  PSA ex- 
pression on the surface of myotubes in vivo was dramati- 
cally  altered  by  neuromuscular  activity  blockade.  Thus, 
while total NCAM expression was only modestly affected 
by activity blockade, PSA immunofluorescence was virtu- 
ally  abolished  during  all  stages  of muscle  development. 
Since  PSA  was  expressed  on  cultured  myotubes  at  the 
time when they initiated  spontaneous  contractions  (third 
day in  culture)  and because  activity blockade  prevented 
the upregulation of PSA in vivo, we decided to test more 
directly the possibility that electrical  activity was regulat- 
ing PSA. Thus spontaneous contractile activity was either 
completely  blocked  by  bath  application  of  TTX  or  in- 
creased by electrically stimulating 7-d-old myotubes (1 pulse/ 
10 s; 24 h/d) for 72 h. 
Chronic exposure to TTX did not affect myotube forma- 
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pression  in  the  presence  of 
TI'X or electrical  stimulation. 
10 d  myotube cultures  grown 
in the presence of 10  -6 M TTX 
for  8  d  were  stained  for 
NCAM  (Mab5E)  (A)  or  for 
PSA  (Mab5A5)  (B).  Similar 
cultures  were electrically stim- 
ulated  at  a  rate  of one pulse 
every 10 s for 72 h, beginning 
on  day  7,  and  stained  for 
NCAM  (C),  or for PSA  (D). 
TTX-treated myotubes (A) ex- 
pressed  similar  levels  of 
NCAM  as  electrically  stimu- 
lated myotubes (C). However, 
5A5  expression  was  dimin- 
ished following TrX treatment 
(B)  and  many  myotubes  did 
not express PSA  (B, long ar- 
rows).  Some  myotubes  (B, 
short arrows) did exhibit  PSA 
expression,  but  this  was,  in 
general,  lower  than  that  for 
electrically  stimulated  myo- 
tubes (D) or those with normal 
levels of spontaneous contrac- 
tions.  ITX-treated  myotubes 
were also generally  of smaller 
diameter than either control or 
electrically  stimulated  myo- 
tubes. Bar, 75 ~m. 
tion but did result in considerably thinner myotubes pre- 
sumably because  of the  reduced  synthesis  of contractile 
proteins (Cerny and Bandman 1986). As occurred in vivo 
(Fredette  et  al.,  1993),  total  NCAM  was  uniformly  ex- 
pressed on myotubes and the level of immunofluorescence 
was not visibly different between TI'X (Fig. 2 A) and elec- 
trically stimulated (Fig. 2  C) myotubes. In contrast, PSA 
expression was very sensitive to myotube activity levels, 
being low to undetectable in myotubes whose activity had 
been blocked (Fig. 2 B) and very high in chronically stimu- 
lated myotubes (Fig. 2 D). PSA expression in these chron- 
ically stimulated myotubes was, in general, higher than in 
control spontaneously contracting myotubes. 
Immunoblot Analysis of  NCAM Isoforms during 
Secondary Myogenesis In Vitro 
Since the mAb 5E does not distinguish among the differ- 
ent  isoforms of NCAM  it  is  possible  that,  although  the 
overall  expression  of NCAM  did  not  change  during  in 
vitro myogenesis, changes in the expression of individual 
isoforms may have occured during specific stages of mus- 
cle  development.  Previous  studies  in  developing  chick 
(Fredette  et  al.,  1993;  Yoshimi  et  al.,  1993)  and  mouse 
muscles  (Covault and  Sanes,  1986)  have shown that  the 
145-kD transmembrane isoform is expressed during early 
myogenesis whereas the  130-kD lipid-linked  isoform be- 
comes  the  predominant  isoform  later  in  development. 
However, since developing muscles in vivo are composed 
of a  heterogeneous population of primary and secondary 
myoblasts and myotubes it is difficult to ascertain whether 
this  in  vivo switch in  isoform expression occurs because 
NCAM isoform expression is regulated  developmentally 
in all cell types or because different populations of muscle 
cells express  different isoforms. For  example, several in 
vitro studies  concluded  that  myoblasts preferentially ex- 
press the  145-kD transmembrane isoform while the  130- 
kD lipid-linked form is expressed on myotubes once fu- 
sion  occurs  (Moore  et  al.,  1987;  Knudsen  et  al.,  1989; 
Tassin et al., 1991). A  previous in vivo study from this lab 
(Fredette  et al.,  1993)  observed that the  145-kD isoform 
predominated  when  muscles were  composed of primary 
myotubes, with expression of the 130-kD isoform being as- 
sociated with secondary myogenesis. 
To clarify this issue, NCAM isoform expression was ex- 
amined  at several stages during in  vitro secondary myo- 
genesis. To determine the  pattern of isoform expression 
the  isoforms were examined with  SDS-PAGE combined 
with  immunoblot  analysis.  Cell  cultures  were  harvested 
and homogenized at 1 d  (homogenous culture of second- 
ary myoblasts), 3 d  (newly formed secondary myotubes), 
and 4-8 d (progressive maturation of myotubes) after plat- 
ing. Half of the tissue homogenates were desialylated with 
neuraminidase  to  remove  the  polysialic  acid  associated 
with the NCAM isoforms. 
The predominance of the different NCAM isoforms var- 
ied with the stage of myogenesis. In agreement with previ- 
ous studies (Knudsen et al., 1989; Tassin et al., 1991), 1-d-old 
myoblast cultures contained NCAM of three different mo- 
lecular weights when desialylated:  155,  145  and  130  kD, 
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Figure 3.  SDS  gel electrophoresis  and immunoblot  analysis of 
NCAM isofonns and degree of polysiaJylation during muscle de- 
velopment in vitro.  (A) Neuraminidase-desialylated  proteins (+ 
lanes) from 1, 3, 4-8 d myotube cultures show that there are pro- 
gressive changes in the proportions of the different NCAM iso- 
forms during  in vitro myogenesis.  Myoblasts  contain primarily 
the 145-kD isoform with lesser amounts of the 155-kD isoform. 
Weak expression of the 130-kD isoform, barely detectable on the 
immunoblot shown in A was confirmed with quantitative densi- 
tometry (see B). The 130- and 155-kD isoforms are up-regulated 
in newly formed, spontaneously contracting  myotubes (3d).  This 
pattern remained relatively constant until 8 d when the relative 
expression of the 155- and 145-kD isoforms decreased compared 
to the 130-kD isoform. NCAM from 1 and 3 d myotube culture 
homogenates that were not treated with neuraminidase was de- 
tected as three discrete  bands (-  lanes)  indicating  that at this 
stage of development NCAM was not polysialylated. In contrast, 
NCAM from 4 d myotubes was detected as a diffuse band run- 
ning between 250-140 kD indicating that actively contracting myo- 
tubes have highly polysialylated NCAM. (B) Quantitative repre- 
sentation  of  the  developmental  changes  in  NCAM  isoform 
expression. Densitometric scans were made of the NCAM immu- 
noblots and the quantity of 155-, 145-, and 130-kD isoforms is ex- 
pressed as  a  percent  of the  total NCAM present.  Values are 
means --- SE from at least three separate experiments. 
with the  145-kD  isoform being most prominent  and  the 
130-kD GPf-linked isoform being only weakly expressed 
(Fig.  3). Newly formed, spontaneously contracting, myo- 
tubes (3-d-old cultures) continued to express all three iso- 
forms; however the expression of the 155-kD isoform had 
now increased sharply with respect to the 145-kD NCAM 
as did, to a lesser extent, the lipid-linked 130-kD isoform. 
1-d later (4-d-old cultures), the expression of the 155- and 
145-kD isoforms had remained relatively constant whereas 
the 130-kD NCAM had increased considerably. This pat- 
tern  of NCAM  expression  remained  relatively constant 
until day 8 when the relative expression of the 155- and the 
145-kD  isoforms  decreased  while  that  of  the  130-kD 
NCAM increased to become the major isoform (Fig. 3, A 
and B). 
The developmental regulation of PSA expression, shown 
previously with  immunostaining,  was  also detectable  on 
immunoblots. NCAM from 1- and 3-d-old muscle culture 
homogenates  that  were  not  treated  with  neuraminidase 
(Fig. 3 A, columns labeled with  -) was detected as three 
discrete  bands running  at only slightly higher  molecular 
weights  than  homogenates that  were  treated  with  neur- 
aminidase  (Fig.  3 A).  In contrast,  NCAM from 4  d  and 
older cultures was detected as a diffuse band between 250- 
140 kD. These results indicate that the NCAM on second- 
ary myoblasts and newly formed myotubes (i.e., 3 d) is not 
polysialylated while NCAM on older, actively contracting 
myotubes is highly polysialylated. These results agree with 
the PSA immunofluorescence which showed that staining 
with  the  mAb 5A5  was not  detectable  on  1-d-old myo- 
blasts and was very weak on 2-d-old myoblasts while it was 
readily detectable on myotubes. These results also show 
that secondary myotubes growing in culture polysialylate 
all three major NCAM isoforms. This contrasts with chick 
muscle development in vivo, where Fredette et al. (1993) 
showed that the 145-kD isoform was not polysialylated at 
times when the  130 and  155  isoforms were. Although  at 
present  we do not  have an explanation  for these  differ- 
ences, it is possible that primary myotubes, which in vivo 
make  a  significant  contribution  to  total  muscle  NCAM, 
sialylate isoforms differently than secondary myotubes. 
Metabolic Labeling of  NCAM lsoforms 
The changes in  NCAM  isoform expression we observed 
could be due to differences in either the rate of synthesis 
of each isoform or their rate of turn-over. For example, it 
is possible that only myoblasts synthesize the 145-kD iso- 
form and that its continued expression on myotubes is due 
to  its  slow rate  of turn-over during  myotube formation. 
Similarly, the switch in the predominant isoform observed 
by 8 d in culture may have resulted because by this stage of 
development the  155-  and 145-kD isoforms were turning 
over more rapidly than  the  130-kD  isoform. Thus, if all 
were synthesized at the same rate, more of the 130-kD iso- 
form would be present at any given time point. 
To  examine  these  possibilities  [35S]methionine  pulse- 
chase experiments were performed on myotube cultures 4 
and 7 d  after plating. As shown in Fig. 4 A, all three iso- 
forms are synthesized in 4-d-old myotube cultures indicat- 
ing that the 145-kD isoform is not only synthesized by myo- 
blasts as previously suggested (Covault et al., 1986; Moore 
et al., 1987) but also by myotubes which at this stage con- 
stitute the vast majority of the NCAM expressing cells in 
these cultures (Fig. 4 A). After 1 or 2 d of chase the level 
of [35S]methionine labeling of all three isoforms of NCAM 
decreased at a similar rate. Optical density measurements 
(Fig. 4 B) indicated that the half life of all three isoforms at 
this stage of development was ~20 h. 
The relative rates of synthesis of the three NCAM iso- 
forms changed markedly between 4 and 7 d in culture (Fig. 
4 C). By 7 d in culture the relative rate of synthesis of the 
130-kD NCAM had greatly increased with respect to the 145- 
and  155-kD  isoforms.  Thus  the  predominance  of  the 
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Figure  4.  Rate  of  synthesis 
and turn-over of newly syn- 
thesized NCAM isoforms at 
4  and 7  d  in cultures.  Myo- 
tube  cultures  were  pulsed 
with  [35S]methionine  for 8 h 
after which the proteins were 
either extracted immediately 
(Od)  or  chased  with 
[35S]methionine-free  medium 
for 1 or 2 d. NCAM was im- 
munoprecipitated and run on 
6%  SDS-PAGE  gets  (see 
Materials  and  Methods  for 
additional  details).  (A)  4-d- 
old myotube cultures synthe- 
size  all  three  "muscle  spe- 
cific" isoforms with the level 
of synthesis of the 145 kD be- 
ing  slightly  higher  than  the 
155-  and  130-kD  isoforms. 
(B) Plotting the optical den- 
sity  measurements  on  semi- 
logarithmic  axes  indicates 
that  at  this  stage  of muscle 
development  all  three  iso- 
forms have a half life of N20 h. 
Note that there is a faint, but 
discernible band at 180 kD in the 0d lane. (C) While 7-d-old myotube cultures also synthesize all three "muscle specific" isoforms, the 
expression pattern dramatically differs from 4 d myotubes; the relative rate of synthesis of the 130-kD isoform is substantially higher 
than either the 155- and 145-kD isoforms. The level of expressison of all three isoforms progressively decreases following a 1 and 2d of 
chase.  (D) Optical density measurements, plotted on semilogarithmic axes, indicates that the turn-over rate of the 130-kD isoform is 
significantly  slower (half-life of 48 h) than both the 155- and 145-kD isoforms (both with half-life of 12 h). Also note that an intense 180- 
kD band can dearly be seen in the 0d lane but is absent following 1 and 2d of chase. (E) Not all NCAM isoforms synthesized in 8 d myo- 
tube cultures are polysialylated. [35S]Methionine-labeled  cultures show that the 130-kD isoform is detectable as a distinct band only 
when the homogenate is treated with neuraminidase (+) and that this band is completely absent in untreated samples (-). In contrast, 
the 180-kD isoform is clearly detectable as a discrete band of essentially the same molecular weight in both untreated (-) and treated 
(+) myotube homogenates. 
130-kD isoform appears to be due, at least in part, to an in- 
creased  rate  of synthesis.  However,  pulse  chase  experi- 
ments also indicated that the turn-over rate of this isoform 
was  slower  compared  to  the  145-  and  155-kD  isoforms. 
From optical density measurements (Fig. 4 D) its half life 
was ~48 h compared to 12 h for both the 145- and 155-kD 
isoforms. Thus, the relative abundance of the GPI-linked 
130 isoform in more mature myotubes appears to be due 
to both an increase  in its  relative  rate  of synthesis  and a 
decrease in its rate of degradation. 
In addition, in both 4  and 7  d  myotube cultures we no- 
ticed a band in the position where the 180-kD NCAM iso- 
form would appear. The 180-kD isoform has been consid- 
ered to be nerve specific (but see Tassin et al., 1991; Lyons 
et  al.,  1992),  and  in most immunoblots  of cultured  myo- 
tubes, there was only a very faint band evident in this posi- 
tion (see for example Fig. 3 A, 4-6 d  cultures). Neverthe- 
less,  in  the  autoradiograms  from  8  d  cultures  (Fig.  4  C, 
0 d), the protein running at this position was being synthe- 
sized  at  a  higher  rate  than  any of the  other NCAM iso- 
forms. However, unlike the 155-, 145-, and 130-kD NCAM 
isoforms, this protein had a very fast turn-over rate, with a 
half-life of less than  8 h, since it was virtually absent fol- 
lowing a 1 d chase (Fig. 4 C, I d). In striking contrast to the 
other  three  isoforms,  the  180-kD  NCAM  was  not  poly- 
sialylated  as  indicated  by  the  distinct  band  running  at 
180-kD from the 8-d-old culture homogenate that was not 
treated with neuraminidase (Fig. 4 E). 
A  protein with a very high molecular weight (>200 kD) 
was frequently immunoprecipitated along with NCAM us- 
ing 5E-conjugated Sepharose beads (for example see Figs. 
4  C  and  7  B).  While  the  identity  of this  protein  is  not 
known, it is clearly not NCAM since it was not recognized 
by either  5E  monoclonal  antibody  (Figs.  3  and  5)  or by 
polyclonal anti-NCAM (data not shown). Preliminary ex- 
periments  indicate that some, but not all, of the material 
running at this position is myosin that bound nonspecifi- 
cally to the beads used in the immunoprecipitation. 
Expression of a I80-kD NCAM Isoform by Skeletal 
Muscle Cells 
Metabolically  labeled  myotubes synthesized  an  apparent 
NCAM isoform with  a  molecular weight of 180 kD (Fig. 
4). Previous studies had indicated that this transmembrane 
NCAM isoform, with a large intracellular domain, was ex- 
clusively synthesized  in  neuronal  tissue,  and  was  absent 
from skeletal muscle (but see Tassin et al., 1991). To better 
characterize the 180-kD isoform of NCAM synthesized in 
muscle,  homogenate  extracts  were  prepared  from St.  37 
chick hindlimb  muscles,  5  d  myotube cultures,  and  from 
sciatic  nerve.  Immunoblots  were  stained  with  either  a 
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developing chick muscle, both in vivo and in vitro.  Neuramini- 
dase-desialylated  proteins, extracted with NP-40 from St 37 sci- 
atic (NERVE), hindlimb  muscles (MUSCLE) and 5d myotube 
cultures (CULTURE) were separated by SDS-PAGE and immu- 
noblotted with  either an mAb that recognizes  all NCAM iso- 
forms (5E) or with an mAb that specifically recognizes only the 
180-kD isoform (4D). The 4D mAb specifically recognized a 180- 
kD isoform in embryonic nerve, muscle and myotube culture ex- 
tracts indicating that this isoform is not exclusively expressed by 
neuronal tissue.  Immunoprecipitated NCAM was separated by 
SDS-PAGE and incubated first with  PNA, and then immuno- 
blotted with  ant-PNA. Peanut lectin  (PL) bound to 180-, 155-, 
and 130-kD NCAM isoforms, but not to the 145-kD isoform indi- 
cating that this isoform does not contain the MSD region. 
mAb that recognized all NCAM isoforms (5E) or with one 
specific  for  the  180-kD  neuronal  isoform  (4D).  Sciatic 
nerve extracts from St 37 chick embryos contained both 
the  140-  and  180-kD  NCAM  isoforms  (Fig.  5,  5E, 
NERVE) and in agreement with Watanabe et al. (1986), 
the  4D  mAb exclusively recognized the  180-kD  isoform 
(Fig. 5, 4D, NERVE). The predominant NCAM isoforms 
observed in  extracts from St  37  chick muscles were  the 
130-,  145-,  and 155-kD isoforms; nevertheless the 180-kD 
isoform was clearly detectable (Fig. 5, 5E, MUSCLE; see 
also Fredette et al., 1993) and recognized by the 4D mAb 
(Fig. 5, 4D, MUSCLE). To rule out the possibility that the 
180-kD  NCAM isoform observed in  the muscle extracts 
was  due  to  NCAM  derived  from  intramuscular  nerves, 
myotube cultures were homogenized and analyzed by im- 
munoblotting with either the 5E (Fig. 5, 5E, CULTURE; 
see also Fig. 3) or 4D (Fig. 5, 4D, CULTURE) mAbs. As 
observed in  the  muscle extracts, cultured  myotubes also 
contained the 180-kD isoform of NCAM. 
The rate of synthesis of the 180-kD isoform in myotube 
cultures  increased  developmentally, being greater at 7  d 
than at 5 d (Fig. 4, A  and C). In addition, its turn-over rate 
was  significantly  faster  than  that  of the  other  isoforms 
since the metabolically labeled 180-kD isoform was com- 
pletely absent with only 1 d of chase (Fig. 4 C). This high 
rate of turn over may explain why the 180-kD isoform is 
only weakly detected in immunoblot analysis (Fig. 3). 
Specific NCAM Isoforms Contain a Peanut Lectin 
Binding Region 
The  155-  and  125-kD  isoforms  of NCAM  from the  C2 
skeletal muscle cell line contain a muscle-specific domain 
(MSD) splice insert which contains an O-linked glycosyla- 
tion site that is recognized by peanut lectin (Walsh et al., 
1989).  To  characterize  the  binding  of  peanut  lectin  to 
NCAM from chick skeletal muscle, NCAM was immuno- 
precipitated  from  5-d-old  secondary  myotube  cultures, 
treated  with  neuraminidase,  separated  by  SDS-PAGE, 
and transferred onto Immobilon-P membranes (see Mate- 
rials  and  Methods  for details).  Binding  of peanut  lectin 
was detected on the  155- and  130-kD isoform bands but 
not on the 145-kD band, indicating that the latter isoform 
lacks the MSD insert (Fig. 5, PL) (see also Yoshimi et al., 
1993).  Peanut  lectin  also  bound  to  the  180-kD  "nerve" 
specific NCAM isoform, indicating that this isoform also 
contains the MSD. Byeon et al. (1995) recently found that 
in embryonic chick cardiac muscle the 125-,  155-, and 185- 
kD NCAM isoforms contained the MSD insert, while the 
145- and 180-kD isoforms did not. 
Molecular Mechanisms Regulating the Synthesis of 
NCAM Isoforms 
Total NCAM is gradually down-regulated along the sur- 
face of embryonic muscle fibers following innervation, de- 
clining around the  time of hatching in chicks (Tosney et 
al., 1986)  and of birth in mammals when it becomes con- 
fined  mainly  to  neuromuscular  junctions  (Covault  and 
Sanes,  1985).  However,  if neuromuscular  activity is  de- 
creased  in  adult  muscles  by  denervation  (Covault  and 
Sanes, 1985,  1986; Covault et al., 1986)  or TTX treatment 
(Covault and Sanes, 1985) there is a rapid up-regulation of 
NCAM. These results show that the overall expression of 
NCAM on neonatal and adult  muscle fibers is regulated 
by neuromuscular  activity. However, at earlier stages of 
embryonic  development  when  overall  NCAM  synthesis 
was not altered by activity blockade (Fredette et al., 1993), 
the synthesis of specific isoforms was. How might electri- 
cal activity be coupled to isoform synthesis? 
Muscle contraction involves a series of events including de- 
polarization of the sarcoplasmic reticulum and the t-tubules, 
activation  of voltage-sensitive  Ca  2+  channels,  release  of 
Ca  2+ from the sarcoplasmic reticulum (SR), Ca2+-depen  - 
dent activation of actin and myosin cross-bridges, and fi- 
nally the reuptake of Ca  2+ back into the SR. Increased lev- 
els of intracellular Ca  2+ are known to be a critical element 
in intracellular signaling for many different cell types. In 
muscle fibers, neurally evoked Ca  2+ release is believed to 
mediate  changes  in  the  synthesis of macromolecules in- 
cluding  ACh  receptors, myosin heavy chains,  and  Ca  2+ 
ATPases (for general review see Pette and Vrbova, 1992). 
To test whether Ca  2+ plays a role in regulating NCAM 
isoform expression, one group of 5-d-old myotube cultures 
was treated with the Ca  2+ channel blocker verapamil for 
2 d, and then homogenized for immunoblot analysis. The 
other group served as a  control. At the time this 7 d  cul- 
ture was analyzed, the  155-  and  130-kD isoforms had al- 
ready been up-regulated, becoming the predominant iso- 
forms, while  the  145-kD  isoform had  been  significantly 
down-regulated (Fig. 6 A, lane 1). In contrast, when volt- 
age-activated Ca  2+ channels were chronically blocked with 
verapamil (Fig. 6 A, lane 2), the 145-kD isoform (arrow) 
now became the  predominant  isoform. Thus, preventing 
the entry of Ca  2÷ resulted in a less mature isoform pattern 
relative to the control, suggesting that Ca  2+ entry during 
spontaneous electrical activity may serve as the first step 
in  triggering  the  developmental  isoform  switch  we  ob- 
served. 
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results  in a dramatic change in NCAM isoform expression.  (A) 
Immunoblot analysis  of NCAM from desialylated  proteins ex- 
tracted from 7 d control myotube cultures  (lane 1) and cultures 
treated for 24 h  with  verapamil (10  -6 M)  (lane 2)  shows that 
blockade of Ca  2÷ channels  results  in a dramatic increase  of the 
145-kD NCAM isoform relative to the 130- and 155-kD isoforms. 
(B) Autoradiograms and optical density scans of 5-d-old cultures 
pulsed with [35S]methionine show that chronic  verapamil treat- 
ment results  in a dramatic decrease in the synthesis  of the 130- 
and 155-kD isoforms of NCAM. This effect can be seen after only 
a 9 h verapamil treatment (lane 2) but is significantly more dra- 
matic after a 20 h treatment (lane 3). 5 d cultures treated for 24 h 
with thapsigargin  (10 mM) (lane 5) or veratridine (10 -7 M) (lane 
6), which would increase  intracellular  Ca  2+, decreased the rela- 
tive expression of the 155-kD isoform with respect to the 130-kD 
isoform. 
To determine the  extent to which this  altered isoform 
expression pattern was due to altered synthesis of individ- 
ual isoforms, 5-d-old cultures were treated with verapamil 
for 1 or 12 h  prior to an 8  h  pulse with  [35S]methionine. 
Verapamil was maintained in the medium for the duration 
of the pulse. Untreated 5-d-old cultures (Fig. 6 B, lane 1) 
synthesized all three isoforms, with the  155- and  130-kD 
isoforms being synthesized at a relatively higher rate com- 
pared to the 145-kD isoform. This was similar to the rela- 
tive amounts of these isoforms detected in immunoblots, 
such as that shown in Fig. 6 A. After a brief 1 h pre-treat- 
ment with verapamil (9 h total treatment), the 145-kD iso- 
form (arrow) was now increased markedly with respect to 
the  155- and  130-kD isoforms. The effect was more dra- 
matic following a  12 h pre-treatment with verapamil (20 h 
total); in this case (Fig. 6 B, lane 3), synthesis of the 155- 
and 130-kD isoforms was completely inhibited,  with only 
the 145-kD isoform still being synthesized. 
IntraceUular Ca  2÷  levels can be increased  with  thapsi- 
gargin,  a  drug  that  specifically inhibits  the  endoplasmic 
reticulum Ca2+-ATPase (Thastrup et al., 1990). As can be 
seen in Fig. 6 B  (lane 5) a  24 h  treatment with this drug, 
had  the  opposite effect of verapamil, producing  a  more 
mature  isoform pattern,  in  which  the  130-kD  predomi- 
nates with lower rates of synthesis of both the  145- and 
155-kD isoforms. Thus these cultures, which were 6-d-old 
at the time of the analysis, had an isoform expression pat- 
tern more like control 8 or 9 d  cultures (see for example 
the immunoblots in Fig. 3 A  and the autoradiogram in Fig. 
4 B). The Na  ÷ channel activator veratradine also produced 
a  more mature isoform pattern (Fig. 6  B, lane 6).  When 
this drug was added to the cultures it produced more fre- 
quent spontaneous contractions, and thus may have indi- 
rectly caused increased entry of Ca  2÷. 
The amount of the  180-kD isoform synthesized varied 
between control cultures of the same age (compare lanes 1 
and 4 in Fig. 6). This could be caused by differences in the 
level  of spontaneous  electrical  activity which  varies be- 
tween cultures.  In support of this possibility, older, more 
actively  contracting  myotubes  consistently  synthesized 
more of the 180-kD NCAM than younger less active myo- 
tubes (for example see Fig. 4). 
Previous studies have indicated that the 180-kD NCAM 
isoform is a substrate for endogenous Ca2÷-activated pro- 
teolysis (Covault et al., 1991; Sheppard et al., 1991). Pulse- 
chase experiments presented  in  this study show that the 
180-kD isoform has a very rapid rate of turn-over (Fig. 4). 
Whether  this  is  due  to  Ca2÷-activated proteolysis is  not 
known. However, consistent with this possibility, blockade 
of voltage-activated Ca2÷channels  with verapamil, which 
would be expected to lower intraceUular Ca  2+, resulted in 
an increase in the amount of the 180-kD isoform (compare 
lanes 1 and 2 in Fig. 6 B). Conversely, thapsigargin or ver- 
atradine, both of which increase the level of intracellular 
Ca  2÷, caused a decrease in the amount of 180-kD NCAM 
(compare lanes 5 and 6 with lane 4 in Fig. 6 B). 
In conclusion, it appears that Ca  2÷ entry via voltage de- 
pendent Ca  2÷ channels has the effect of increasing the syn- 
thesis of the 155- and 130-kD isoforms relative to that of 
the  145-kD  form. Since  these  different NCAM isoforms 
arise by alternative splicing from a single gene, the entry of 
Ca  z÷ via voltage sensitive channels appears to be the first 
step  in  the  pathway by which  electrical  activity controls 
the developmentally regulated isoform switch we have de- 
scribed. We therefore decided to explore possible down- 
stream consequences of this intial step. 
Another molecule, whose synthesis is known to be regu- 
lated by electrical activity, is the AChR. Synthesis of this 
receptor in nonsynaptic nuclei is down-regulated following 
initial innervation and activation of myotubes, but is rap- 
idly  restored  following  denervation  (Berg  et  al.,  1972; 
Miledi and Potter, 1971). More recent studies have impli- 
cated entry of Ca  2÷ and activation of PKC in this down- 
regulation. Denervation of chick hind limb muscles (Huang 
et  al.,  1992)  or blockade of spontaneous  contractions  in 
cultured myotubes with TTX (Klarsfeld et al., 1989; Men- 
delzon et al., 1994) causes a dramatic decrease in nuclear 
PKC  activity  and  an  increase  in  the  level  of  AChR 
mRNA. In addition, inhibition of PKC activity with selec- 
tive inhibitors leads to an increase in AChR mRNA syn- 
thesis in both TI'X-treated cultured  myotubes (Fontaine 
et al., 1987; Klarsfeld et al., 1989) and in denervated chick 
muscles (Huang et  al.,  1992).  Since  the  developmentally 
regulated  NCAM  isoform switch  we  observed was  also 
sensitive to activity and appeared to require entry of Ca  2+, 
we examined the possible involvement of PKC in this reg- 
ulation. 
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in NCAM isoform expression. (A) Immunoblots and optical den- 
sity scans of NCAM from desialylated proteins extracted from 7 d 
control  myotube cultures  (lane  1) and cultures  treated for 24 h 
(lane 2) and 72 h (lane 3) with TPA (10 -6 M) (lane 2) shows that 
inhibition  of PKC results in a significant increase  in the 145-kD 
NCAM isoform relative to the 130- and 155-kD isoforms. Synthe- 
sis of NCAM isoforms following treatment with staurosporine or 
long-term TPA. Control 5 day cultures show that synthesis of the 
145-kD isoform (lane 1, arrow) is lower than that of the 155- and 
130-kD isoforms. 5-d-old cultures treated for 20 h with staurospo- 
rine  (10 -7  M)  (lane  2)  or  long-term TPA  (10 -6 M)  (lane 3) 
resulted  in increased  synthesis  of the  145-kD  isoform (arrow) 
relative to the other two isoforms. (C) Inhibition of phosphatidyl- 
choline metabolism with D609 (30 mM) (lane 4) mimics the ef- 
fects seen with chronic TPA treatment. 
5-d-old myotube cultures were treated with the phorbol 
ester, TPA (10  -6 M), for 24 or 72 h  and subsequently ho- 
mogenized to assess NCAM expression using SDS-PAGE 
combined with immunoblot analysis. Continuous applica- 
tion  of  this  concentration  of TPA  has  previously  been 
shown  to  substantially deplete  PKC in  nuclear  fractions 
from chick muscle fibers after 16 h of treatment (Huang et 
al., 1992).  After a 24 h treatment with TPA the expression 
pattern of NCAM isoforms on cultured myotubes differed 
significantly from untreated control cultures. The control 
cultures of this stage, the level of the 145-kD NCAM was 
substantially  lower  than  the  155-  and  130-kD  isoforms 
(Fig. 7 A, lane 1, arrow),  whereas in the cultures treated 
with TPA for 24 h, all three isoforms were being expressed 
at approximately equivalent levels (Fig. 7 A, lane 2). Thus 
it appeared that the 145-kD isoform had been significantly 
increased  relative  to the  other  two isoforms. This effect 
was even more obvious following a  72 h  treatment when 
the 145-kD isoform was the only isoform detected (Fig. 7 
A,  lane  3).  Similar  results  were  obained  when  relative 
rates  of  isoform  synthesis  were  measured  in  cultures 
pulsed with [35S]methionine following treatment with stau- 
rosporine  or  long-term  TPA  treatment,  both  of  which 
would be expected to down-regulate PKC. As seen in Fig. 
7  B  (lanes  1-3),  both  of these  treatments  increased  the 
synthesis of the 145-kD isoform relative to the other two 
isoforms. 
In summary, blocking Ca  2+ entry via voltage-dependent 
Ca  2÷ channels or inhibiting  PKC appeared to selectively 
inhibit the synthesis of the 130- and 155-kD isoforms while 
increasing that of the 145-kD isoform. 
PKC is activated by Ca  2÷  and diacylglycerol following 
hydrolysis  of  phosphatidylinositol  and/or  phosphatidyl- 
choline.  Hydrolysis of the latter is believed to result in a 
more  sustained  elevation  in  diacylglycerol which  conse- 
quently  sustains  the  activation  of  PKC  (Asaoka  et  al., 
1992).  The phospholipid that supplies diacylglycerol dur- 
ing neuromuscular activity is not known. However, studies 
on Ascaris suum muscles have shown that ACh stimulates 
phosphatidylcholine metabolism (Arevalo and Saz, 1992). 
To determine whether sustained activation of PKC, via the 
phosphatidylcholine pathway, is required for the develop- 
mental switch in NCAM isoform expression 5-d-old myo- 
tube cultures were treated for 48 h with a selective inhibi- 
tor of phosphatidylcholine-specific phospholipase C (D609). 
As was observed with long-term TPA treatment, inhibi- 
tion  of PKC activation with D609  altered the pattern  of 
NCAM isoform expression such that the  145 kD became 
the predominant isoform of NCAM (Fig. 7 B). 
Molecular Mechanisms Regulating the Polysialylation 
of NCAM 
As shown above, electrical activity appears to control the 
alternative splicing of NCAM isoforms via influx of Ca  2+ 
and activation of PKC. Since activity was also shown to be 
required  for the  polysialylation of NCAM,  we  explored 
the possibility that this might be mediated by a similar in- 
tracellular signaling pathway. Although not as extensively 
investigated as the isoform switch,  our data is consistent 
with this possibility. As shown in the immunoblot in Fig. 8 
A, untreated  NCAM from 4  d  cultured  myotubes ran  as 
diffuse smear (lane 1).  Treatment with the  PSA specific 
endoneuraminidase  (lane 2)  altered  the  mobility of that 
portion of the  NCAM running  above the  indicated  line, 
which  we  operationally define  as  polysialylated NCAM. 
As shown in Fig. 8 B, a 24 h treatment with TPA (lane 3) 
reduced the proportion of the NCAM running above this 
line as compared to the control (lane 1), as did a 24 h treat- 
ment  with  verapamil (lane  5).  Correlated  with  this,  dis- 
crete  bands,  representing  nonsialylated  NCAM,  became 
discernable  in the untreated  sample (Fig.  8,  indicated  by 
stars in lanes 3  and 5). Verapamil treatment for 24 h  was 
more effective than 24 h  of TPA, both in reducing poly- 
sialylation  and  bringing  about  the  isoform switch  (com- 
pare lanes 2, 4, and 6). This would be expected since ver- 
apamil would  have blocked Ca  2÷  entry for the  full 24  h 
while PKC activity is only reduced by long term TPA after 
~16 h (Huang et al., 1992).  The autoradiogram in Fig. 8 C 
shows that the NCAM being synthesized in the verapamil 
treated cultures at the 24 h time point, is all of the 145-kD 
isoform and that it is not sialylated (the mobility of the dis- 
cete band marked by the star in the untreated sample of 
lane 1 is not altered by neuraminidase treatment, lane 2). 
In summary, as was shown for the isoform switch, electri- 
cal activity appears to regulate NCAM polysialylation via 
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and total NCAM on cultured 
myotubes treated with TPA or 
verapamil.  (A) NCAM immu- 
noblots, from 4 d myotube cul- 
tures,  that  were  untreated 
(lane 1) or treated with  endo- 
neuraminidase  (lane  2)  or 
neuraminidase  (lane  3).  The 
NCAM running above the line 
in lane  1  had  its  mobility  al- 
tered following treatment with 
the  PSA  specific  endo- 
neuraminidase  (lane  2)  and 
thus  represents  the  polysialy- 
lated  NCAM.  (B)  Immuno- 
blots from similar cultures that 
were untreated (lanes 1 and 2) 
or treated  for 24 h  with TPA 
(lanes  3  and  4)  or  verapamil 
(lanes 5 and 6).  After 24 h  of 
treatment  with TPA (lane 3), 
the  proportion  of  polysialy- 
lated  NCAM,  running  above 
the line,  is reduced compared 
to the control (lane 1). In addi- 
tion  distinct  bands  represent- 
ing  145/155-kD  and  the  130- 
kD NCAM (indicated by stars) 
become  visible  even  without 
neuraminidase treatment.  The 
switch  from the 155- and 130- 
kD  isoforms toward  the  145- 
kD isoform described earlier is also seen (compare lanes 2 and 4). After treatment with verapamil for 24 h both the reduction in the 
proportion of polysialylated NCAM (lane 5) and the switch toward expression of the 145-kD isoform, indicated by the star (lanes 5 and 
6), is more complete (see text for additional explanation). (C) An audoradiograph from a similar  culture treated for 24 h with verap- 
amil, shows that the metabolically labeled NCAM being synthesied at this time (lane 1, without neuraminidase treatment) is almost en- 
tirely the 145-kD isoform and is not sialylated (the mobility of a distinct band at this position is identical in the untreated (lane 1) and 
neuraminidase treated (lane 2) sample. (D-F) Cultures immunostained to visualize total NCAM expression. 4 d myotube cultures were 
either untreated (D) or treated for 24 h with verapamil (16 p~M) (F) or TPA (10 -6 M) (E) and immunostained with mAb 5E that recog- 
nizes all NCAM isoforms. NCAM levels and distribution were generally similar in all cases. Overall, myotube morphology  was also sim- 
ilar except in the TPA treated cultures where some of the myotubes appeared to be more flattened and less uniformly cylindrical.  E, en- 
doneuraminidase; N, neuraminidase. Bar, 15 p~m. 
an  intracellular  signalling  pathway  involving Ca  2+  influx 
and PKC. 
Long-term treatments with verapamil or TPA produced 
dramatic  alterations  in  the  proportion  of  the  different 
NCAM isoforms expressed and in their level of sialylation. 
Nevertheless, myotubes in such cultures remained healthy 
in  appearance  and  retained  a  typical myotube morphol- 
ogy. In addition, immunostaining with mAb 5E, revealed 
that both TPA (Fig. 8 E) and verapamil (Fig. 8 F) treated 
myotubes continued  to express  NCAM with  a  level  and 
distribution similar to controls (Fig. 8 D). 
Discussion 
Expression and Regulation of NCAM and PSA during 
In Vitro Myogenesis 
The  present  study  confirms  the  results  of  Mege  et  al. 
(1992) showing that NCAM is strongly and uniformly ex- 
pressed by myogenic ceils throughout in vitro myogenesis. 
NCAM  is  prevalent  on  cultured  myoblasts  and,  unlike 
N-cadherin (Hahn and Covault, 1992; Mege et al., 1992), is 
not  down-regulated  in  older,  spontaneously  contracting 
myotubes. This temporal pattern of expression is similar to 
that observed during in vivo development of chicken mus- 
cle,  in which N-cadherin  is rapidly down-regulated  (Fre- 
dette et al., 1993; Hahn and Covault, 1992), while NCAM 
continues to be expressed for at least a week after muscle 
fibers begin to be electrically activated by neurons (Bekoff 
et  al.,  1975; O'Donovan and  Landmesser,  1987).  NCAM 
declines  only  around  the  time  of hatching  in  the  chick 
(Tosney et al., 1986) and birth in the mouse (Covault and 
Sanes, 1985). 
In contrast, we found that the polysialylation of NCAM 
was developmentally regulated during secondary myogen- 
esis in vitro and that this was controlled by electrical activ- 
ity. Previous observations had indicated that PSA synthe- 
sis  by myotubes in vivo was  either  directly or indirectly 
regulated  by neuromuscular  activity since  activity block- 
ade by dTC prevented its usual up-regulation during sec- 
ondary myogenesis (Fredette et al., 1993). However these 
results might have been explained by some direct effect of 
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ronal" et7 AChRs, which are both present on chick myo- 
tubes  at  early  developmental  stages  (Corriveau  et  al., 
1995). The present results show that it is indeed blockade 
of electrical activity and not some pharmacological effect 
of dTC  that  prevents  PSA  expression.  Specifically, the 
level  of  PSA  immunostaining  increased  sharply  when 
newly formed myotubes began to spontaneously contract. 
Furthermore, it was greatly reduced in myotube cultures 
treated with TTX to block spontaneous contractions and 
was increased in cultures that were electrically stimulated 
to increase the frequency of contractions. Together, the 
present results provide strong support for the hypothesis 
that neuromuscular activity is an important factor regulat- 
ing PSA synthesis in muscle during development. Interest- 
ingly,  not  all  cultured  myotubes  expressed  PSA  even 
though they were well formed and stained intensely for to- 
tal NCAM. Upon visual inspection of the cultures, it was 
clear that  some  myotubes were not  spontaneously con- 
tracting nor could they be induced to contract with electri- 
cal stimulation. It is therefore possible that the myotubes 
that did not express PSA were the same ones that did not 
exhibit spontaneous contractile activity. 
It is  not yet known how neuromuscular activity regu- 
lates NCAM polysialylation. Recently, Bruses et al. (1995) 
found that PSA expression in developing chick ciliary gan- 
glia appeared to be regulated at the level of a polysialyl- 
transferase whose activity correlated well with temporal 
patterns of PSA expression. It is possible that polysialyl- 
transferase activity also regulates PSA synthesis in devel- 
oping muscle such that the absence of PSA on proliferat- 
ing  myoblasts  and  newly  formed  myotubes  is  because 
these cells do not yet contain sufficient levels of active poly- 
sialyltransferase. If PSA synthesis by muscle is shown to 
be regulated at the level of the polysialyltransferase, our 
overall results would strongly suggest that either the syn- 
thesis or the  activity of the relevant sialyltransferases is 
controlled, at least in part, by electrical activity, and that 
the  intracellular  signaling  pathway  involves  Ca  2+  influx 
and PKC. 
Interestingly, while mature myotubes in culture synthe- 
size four different isoforms of NCAM not all are polysialy- 
lated. In contrast to the other isoforms, the  180-kD iso- 
form  was  not  polysialylated  even  though  it  was  the 
predominant form being synthesized (Fig. 4 E). How such 
selective isoform polysialylation occurs is not known. Sev- 
eral studies have reported selective sialylation of different 
NCAM isoforms in both brain (Breen et al., 1987; Breen 
and Regan, 1988; Bartsch, 1990), and in developing chick 
muscle (Fredette et al.,  1993). However, both brain and 
developing muscle are highly heterogeneous with respect 
to the type of cells they contain and their stage of develop- 
ment (i.e., myoblasts vs. myotubes and/or primary vs. sec- 
ondary myotubes). It is thus possible that the sialylated 
and nonsialylated isoforms observed in the above studies 
were being synthesized by different cell types. However, 
the present observations strongly suggest that an individ- 
ual cell is capable of preferentially polysialylating different 
isoforms, since in the developmentally homogeneous pop- 
ulation of myotubes in our cultures the 130-, 145-, and 155- 
kD isoforms were polysialylated while the 180-kD isoform 
was not. 
Expression of NCAM Isoforms during Myogenesis 
In Vitro 
We have shown in the present study that the expression of 
specific NCAM  isoforms is temporally regulated during 
chick muscle development in vitro, generally confirming a 
number of earlier studies (Covault et al., 1986; Moore et 
al., 1987; Tassin et al., 1991). Several of these studies, using 
both  primary  cultures  of muscle  cells  (Knudsen  et  al., 
1989; Tassin et al., 1991; but see Yoshimi et al., 1993) and 
muscle cell lines (Moore et al.,  1987), reported that myo- 
blasts express only the 145-kD isoform while the 130-kD 
isoform is  expressed by myotubes at the time of fusion. 
However, it is clear from our metabolic labeling results 
that the synthesis of the 145-kD NCAM is not restricted to 
myoblasts since both newly formed and mature myotubes 
in culture continue to synthesize the 145-kD as well as the 
155-  and  130-kD  isoforms.  In  addition,  following treat- 
ments with drugs that caused our cultures to express pri- 
marily the 145-kD isoform (for example, long-term TPA), 
immunostaining  revealed  that  this  NCAM  isoform was 
distributed  uniformly in well-formed myotubes and was 
not concentrated on nor confined to myoblasts. 
Earlier  studies  of  NCAM  isoform  expression  during 
heart (Hoffman et al., 1990) and skeletal muscle (Fredette 
et al., 1993) development considered the 180-kD isoform 
to be of neural origin (however see Tassin et al., 1991; Ly- 
ons et  al.,  1992).  The present  study, however, indicates 
that the 180-kD isoform is indeed expressed by developing 
skeletal  muscles.  Very  recent  observations  have  shown 
that developing heart muscle expresses both 180- and 185- 
kD isoforms of NCAM with the latter containing the MSD 
insert (Byeon et al., 1995). The present metabolic labeling 
studies  of myotube cultures indicate that  the  180-kD  is 
also synthesized at a high rate. 
Regulation of NCAM Isoform Expression during 
In Vitro Myogenesis 
During avian muscle development in vivo (Covault et al., 
1986; Fredette et al.,  1993; Yoshimi et al.,  1993), and in 
vitro (this study; Covault et al., 1986; Tassin et al., 1991; 
Yoshimi et al., 1993; Lyles et al., 1993), the predominantly 
expressed NCAM  isoform switches from the  transmem- 
brane 145-kD to the GPI-linked 130-kD isoform. In vivo, 
this developmental switch, due to alternative splicing, ap- 
pears to be regulated by neuromuscular activity since it 
does not occur if activity is chronically blocked (Fredette 
et al., 1993). 
The  present  study  has  begun  to  define  the  signaling 
events that link electrical activity at the cell surface to the 
regulation of NCAM alternative splicing. Specifically we 
have found that an increase in intracellular Ca  2÷ levels and 
subsequent activation of PKC appear to regulate this de- 
velopmental isoform switch, at least in cultured myotubes. 
Blockade  of Ca  z+  influx through voltage sensitive  Ca  2+ 
channels by verapamil, or inhibition of PKC by staurospo- 
rine or long-term TPA treatment increased the synthesis 
of the 145-kD isoform, while decreasing the synthesis of 
both the 155- and the 130-kD isoforms. In contrast, treat- 
ing with drugs that presumably would increase intracellu- 
lar Ca  2+ levels, such as veratradine, (a sodium channel ac- 
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contractions),  or thapsigargin  (a  Ca2+-ATPase  inhibitor 
that prevents the resequestration of cytoplasmic Ca  2+) in- 
creased the synthesis of the 130-kD NCAM. 
The observations that we and others have made show 
striking similarities between the regulation of NCAM and 
the AChR. The level of expression of both AChRs (Betz 
and  Changeux,  1979)  and  NCAM  (Covault  and  Sanes, 
1986)  is  down-regulated  by neuromuscular  activity  and 
dramatically up-regulated following activity blockade (Co- 
vault and Sanes, 1985). This up-regulation of both AChRs 
and  NCAM  is  prevented by electrically stimulating  the 
denervated  muscle  fibers  (Lomo  and  Westgaard,  1975; 
Goldman et al., 1988;  Covault and Sanes, 1985). Several 
studies have proposed that Ca  2+ and PKC are involved in 
a second messenger cascade that couples membrane depo- 
larization  with  transcriptional  factors  that  regulate  the 
synthesis of the AChR. Membrane depolarization causes a 
transient increase in intracellular Ca  2÷ and translocation 
of PKC (Richter et al.,  1987) while blocking depolariza- 
tion causes a decrease in nuclear PKC activity (Huang et 
al., 1992; Mendelzon et al., 1994). Blockers of voltage-acti- 
vated Ca  2÷ channels increase the expression (Shainberg et 
al., 1976) and synthesis (Klarsfeld et al., 1989; Huang et al., 
1994) of AChRs in muscle cultures. Similarly, inhibition of 
PKC increases AChR et subunit synthesis in cultured myo- 
tubes (Klarsfeld et al., 1989). 
The precise mechanisms by which Ca  2÷ ions and PKC 
regulate alternative splicing of NCAM during muscle de- 
velopment  are  not  understood.  Recently,  Huang  et  al. 
(1993)  showed that  the  myogenic factor, myogenin, de- 
clines rapidly in electrically stimulated denervated chick 
muscle at a rate comparable to the decline in AChR gene 
activation.  They also  showed that  myogenin gene  tran- 
scription was blocked by PKC inhibitors. One possible ex- 
planation  for the  regulation  of NCAM  isoforms is  that 
membrane depolarization leads to both an increase in in- 
tracellular Ca  2÷ and translocation of the Ca2÷-dependent 
PKC into the nucleus where it phosphorylates myogenic 
transcription and/or splicing factors which in turn regulate 
the alternative splicing of NCAM. Mendelzon et al. (1994) 
recently proposed that the repression of AChR biosynthe- 
sis by membrane depolarization results from the phosphor- 
ylation of myogenin via the PKC second messenger path- 
way. Phosphorylation of myogenin inhibits its binding to 
DNA  which  in  turn  prevents  the  transcription  of  the 
AChR  (Mendelzon et  al.,  1994).  Whether myogenin or 
other myogenic transcription factors are involved in alter- 
native splicing of NCAM is currently under investigation. 
NCAM, PSA, and Neuromuscular Development 
The precise  roles played by PSA  and  the  different iso- 
forms of NCAM  in promoting skeletal  myogenesis and 
synapse formation are not known. Since the gross locomo- 
tor capabilities of NCAM-deficient mice appear to be nor- 
mal (Cremer et al., 1994), NCAM and PSA do not seem to 
be essential for many aspects of neuromuscular develop- 
ment. However, it is possible that other cell adhesion mol- 
ecules compensated for the  loss of NCAM  and PSA in 
these  animals.  For  example,  while  PSA  is  unique  to 
NCAM, its proposed function in reducing some of the mo- 
lecular interactions involved in  adhesion/signaling  could 
be compensated for by a number of other molecular alter- 
ations that also affect adhesion or signaling. Alternatively, 
several different molecular interactions may contribute to 
ensure that a specific developmental process takes place, 
but either alone may suffice. For example, the separation 
of secondary myotubes from clusters  is  associated  with 
both a down regulation of N-cadherin and an up-regula- 
tion of PSA, both of which would reduce adhesion. How- 
ever, either one of these alterations in adhesion molecule 
expression may be sufficient for separation to occur. Thus 
PSA expression would only become critical for this pro- 
cess in situtations where the  down regulation of N-cad- 
herin failed to occur. Finally, more detailed observations 
of these NCAM-deficient mice may reveal alterations in 
neuromuscular development that are not detectable at the 
behavioral level, or alternately that are compensated for 
by subsequent developmental processes. 
A  number of observations do indicate that NCAM and 
PSA are significantly involved in myogenesis and neuro- 
muscular  development. Fusion of C2 myoblasts was  en- 
hanced when they were transfected with  a  human  gene 
construct for either the GPI-linked (Dickson et al., 1990) 
or the  140-kD  transmembrane  (Peck and  Walsh.,  1993) 
NCAM  isoform. In contrast, removal of the GPI-linked 
isoform from myoblasts  with  phospholipase  C  retarded 
myotube fusion (Knudsen et al., 1989). In vivo, injection of 
anti-NCAM reduced the number and length of intramus- 
cular nerve branches (Landmesser et al.,  1988) and PSA 
removal  resulted in  a  reduction in  both neuromuscular 
synapse  formation  and  motoneuron  survival  (Tang  and 
Landmesser, 1993). Finally, activity blockade, which pre- 
vents the expression of PSA on myotubes, but not nerve, 
interfered with the separation of myotubes from myotube 
clusters (Fredette et al., 1993). In the adult, other studies 
provide evidence that  NCAM  promotes  nerve terminal 
sprouting following localized paralysis (Booth et al., 1990) 
and that it enhances the rate of neuromuscular reinnerva- 
tion following partial denervation (Langfeld-Oster et al., 
1994). 
The tightly and differentially regulated pattern of NCAM 
isoform expression during in vivo neuromuscular develop- 
ment suggests that these alternately spliced isoforms are 
playing distinct  roles.  Since only the  145-kD  isoform is 
present when  primary myotubes form and when  nerves 
first branch and synapse within muscle, it is most likely re- 
sponsible  for mediating  some  of the  NCAM-dependent 
nerve-muscle interactions described above. The up-regu- 
lation of the 130-kD isoform only at the onset of second- 
ary myogenesis and its persistence in the adult  suggests 
that it may be playing other roles. However, thus far there 
is  only limited  in  vitro  evidence on  different effects of 
NCAM  isoforms.  Specifically,  Peck  and  Walsh  (1993) 
have shown that the 140-kD isoform is more effective in 
enhancing myotube fusion in culture than the GPI-linked 
MSD  containing  isoform.  Clearly,  further  experiments 
that specifically addresss this question, both in vitro and in 
the animal are needed. 
In summary, the culture paradigm that we have devel- 
oped should be a useful one in which to further elucidate 
the cellular pathways by which overall NCAM gene tran- 
scription as well as the synthesis of alternatively spliced 
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culture  the  predominant  NCAM  isoform  expressed  by 
these myotubes, should allow us to better determine the 
role played by individual isoforms in muscle-muscle cell 
interactions such as myoblast alignment, fusion, and sepa- 
ration, as well as in nerve-muscle interactions, including 
neurite growth, branching, and the formation and stabili- 
zation of synapses. 
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